Abstract:Yu Li, 1, &ast Mei-Ling Wang, 1, &ast Bo Zhang, 1 Xiao-Xu Fan, 1 Qin Tang, 1 Xue Yu, 2 Li-Na Li, 2 Ang-Ran Fan, 2 Hong-Sheng Chang, 1 Lan-Zhen Zhang 1 1 School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, People's Republic of China; 2 School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lan-Zhen Zhang; Hong-Sheng Chang, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Northeast Corner of the Intersection of Sunshine South Street and Baiyang East Road, Fangshan District, Beijing, 102488, People's Republic of China, Tel +86 10 5391 2122, Email ; Background: There is growing evidence to suggest that ginsenoside Rd (GRd) has a therapeutic effect on depression, but the specific mechanisms behind its activity require further study. Objective: This study is designed to investigate the antidepressant-like effect and underlying mechanisms of GRd. Methods: In this study, the behavioral despair mouse model of depression and chronic unpredictable mild stress (CUMS) rat model of depression were established to explore the effects of GRd on depression-like behavior and its underlying mechanisms. Behavioral tests were used to evaluate the replication of animal models and depression-like behaviors. The hypoxia-inducible factor-1α (HIF-1α) blocker 2-methoxyestradiol (2-ME) was injected to determine the role of HIF-1α in the antidepressant-like effect of GRd. In addition, molecular biology techniques were used to determine the mRNA and protein expression of HIF-1ɑ signaling pathway and synaptic plasticity-related regulators, that is synapsin 1 (SYN 1) and postsynaptic density protein 95 (PSD 95). In silico binding interaction studies of GRd with focused target proteins were performed using molecular docking to predict the affinity and optimal binding mode between ligands and receptors. Results: Our data show that GRd significantly reversed depression-like behavior and promoted mRNA and protein expression of HIF-1ɑ signaling pathway and synaptic plasticity-related regulators. However, the antidepressant-like effect of GRd disappeared upon inhibition of HIF-1α expression following administration of 2-ME. Furthermore, molecular docking results showed that GRd possessed significant binding affinity for HIF-1α, VEGF, and VEGFR-2. Conclusion: Our results show that GRd exhibits significant antidepressant-like effect and that HIF-1α signaling pathway is a promising target for the treatment of depression. Keywords: ginsenoside Rd, antidepressant effect, HIF-1α-VEGF signaling pathway, VEGFR-2, synaptic plasticity-related regulators, molecular docking Depression is a mental affective disorder characterized by significant and long-time decreased interest, low mood, slow thinking, activity decline, and loss of appetite, which seriously affects the physical and mental health of patients. 1 According to a report from the World Health Organization, depression is predicted to become the main cause of the global burden of disease by 2030. 2 At present, the treatment strategy for depression still involves selective serotonin (5-HT) reuptake inhibitors (SSRIs) which have been traditionally used in the clinic. Unfortunately, SSRIs do not meet the criteria for an excellent therapy, including rapid onset of action, high curative rate, and fewer side effects. SSRIs are ineffective in up to 35% of patients and they cause many side effects, such as gastrointestinal adverse reactions (particularly nausea and vomiting) and neurological side effects (especially headaches and tremors). 3–5 Moreover, depression has become a serious worldwide public health problem and its complicated pathological mechanisms need to be further explored. Consequently, addressing this unmet need requires further study to develop safe and effective antidepressant drugs and explore innovative mechanisms of action. Panax ginseng Meyer, a precious traditional Chinese medicine, is indigenous to the Far East countries (most notably China and Korea). 6 According to the Pharmacopoeia of the People's Republic of China (2020), it has the effect of reinforcing vital energy, calming the mind, and boosting cognitive functions. Further, antidepressant was one of the clinical indications of ginseng according to traditional Chinese medicine, with ginseng extract also being reported to improve depression in postmenopausal women. 7,8 Modern research has proven that ginsenosides are the active i -Abstract Truncated-

Ginsenosides modulate hypothalamic-pituitary-adrenal function by inhibiting FKBP51 on glucocorticoid receptor to ameliorate depression in mice exposed to chronic unpredictable mild stress

Ginsenoside Rg1 ameliorates depressive-like behavior by inhibiting NLRP3 inflammasome activation in mice exposed to chronic stress

Ginsenoside Rb1 Induces a Pro-Neurogenic Microglial Phenotype Via PPARγ Activation in Male Mice Exposed to Chronic Mild Stress

Antidepressive effects of ginsenoside Rg1 via regulation of HPA and HPG axis.

Geniposide exerts the antidepressant effect by affecting inflammation and glucose metabolism in a mouse model of depression

Ginsenoside-Rg1 Rescues Stress-Induced Depression-Like Behaviors via Suppression of Oxidative Stress and Neural Inflammation in Rats

Ginseng total saponins and Fuzi total alkaloids exert antidepressant-like effects in ovariectomized mice through BDNF-mTORC1, autophagy and peripheral metabolic pathways

Sesquiterpenoids from the Root of Panax Ginseng Attenuates Lipopolysaccharide-Induced Depressive-Like Behavior Through the Brain-Derived Neurotrophic Factor/Tropomyosin-Related Kinase B and Sirtuin Type 1/nuclear Factor-κB Signaling Pathways

Role of ginsenoside Rb1 in attenuating depression-like symptoms through astrocytic and microglial complement C3 pathway

The Antidepressant Effects of Ginsenoside Rg1 and Rb1 Are Involved in Regulating NMDAR1 Phosphorylation Via Mtor-Akt-nf-kappa B Pathway in CUMS Mouse Model

Antidepressant-Like Effect and Mechanism of Ginsenoside Rd on Rodent Models of Depression

An Integrative Pharmacology-Based Pattern to Uncover the Pharmacological Mechanism of Ginsenoside H Dripping Pills in the Treatment of Depression

Korean red ginseng alleviate depressive disorder by improving astrocyte gap junction function

Genipin 1-O-β-D-gentiobioside ameliorates CUMS-induced prefrontal cortex neuron neuronal apoptosis by modulating HIPK2 SUMOylation

Ginsenoside Re Prevents Depression-like Behaviors via Inhibition of Inflammation, Oxidative Stress, and Activating BDNF/TrkB/ERK/CREB Signaling: An In Vivo and In Vitro Study

Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy

Effects of notoginsenoside R1 on attenuating depressive behavior induced by chronic stress in rats through induction of PI3K/AKT/NF-κB pathway

Role of PGC-1α Mediated Synaptic Plasticity, Mitochondrial Function, and Neuroinflammation in the Antidepressant Effect of Zi-Shui-Qing-Gan-Yin

Antidepressant Effects of Ginsenosides from Panax Notoginseng

PGC-1α in the hippocampus mediates depressive-like and stress-coping behaviours and regulates excitatory synapses in the dentate gyrus in mice

Ginsenoside Rh2 administration produces crucial antidepressant-like effects in a CUMS-induced mice model of depression